CDKN2A and cancer: In the present study, we assessed the germline status in CDKN2A‐negative individuals with a clear high melanoma‐risk profile, defined either by multiple primary melanomas in the index patient or by multiple family members with a melanoma diagnosis, across a targeted gene panel of 360 cancer‐related genes.